Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Stefan Mazgareanu"'
Publikováno v:
Drug Design, Development and Therapy, Vol 2009, Iss default, Pp 143-149 (2009)
Matthias Rother1,2, Egbert J Seidel3, Priscilla M Clarkson4, Stefan Mazgareanu1, Ulrich Vierl1, ilka Rother21IDEA AG, Muenchen, Germany; 2X-pert Med GmbH, Graefelfing, Germany; 3Department Physical and Rehabilitation Medicine, Sophien- and Hufeland-C
Externí odkaz:
https://doaj.org/article/c815fb088e07482a97709c9b2eceecd0
Autor:
Sascha Ott, Farnoush Alborzi, Markus van der Giet, Felix Schoenrath, Julia Stein, Stefan Mazgareanu, Alexander Meyer, Volkmar Falk, Maren Godde, Isabell Anna Just, Kai M. Schmidt-Ott
Publikováno v:
Journal of Cardiothoracic and Vascular Anesthesia. 36:444-451
Acute kidney injury (AKI) is a common complication after cardiac surgery (CS). Because a therapeutic regimen remains scarce, the early implementation of preventive strategies is crucial. The authors investigated risk factors and the typical clinical
Autor:
Rasmus Gantzel, Markus Meyer, Stefan Mazgareanu, Niels Kristian Aagaard, Peter Jepsen, Johannes Holzmeister, Hugh Watson, Henning Grønbæk
Publikováno v:
Gantzel, R H, Meyer, M, Mazgareanu, S, Aagaard, N K, Jepsen, P, Holzmeister, J, Watson, H & Grønbæk, H 2021, ' Ularitide as treatment of refractory ascites in cirrhosis-a study protocol for a randomised trial ', Danish Medical Journal, vol. 68, no. 12, A07210610 . < https://ugeskriftet.dk/dmj/ularitide-treatment-refractory-ascites-cirrhosis-study-protocol-randomised-trial >
Gantzel, R H, Meyer, M, Mazgareanu, S, Aagaard, N K, Jepsen, P, Holzmeister, J, Watson, H & Grønbæk, H 2021, ' Ularitide as treatment of refractory ascites in cirrhosis – a study protocol for a randomised trial ', Danish Medical Journal, vol. 68, no. 12, A07210610 .
Aarhus University
Gantzel, R H, Meyer, M, Mazgareanu, S, Aagaard, N K, Jepsen, P, Holzmeister, J, Watson, H & Grønbæk, H 2021, ' Ularitide as treatment of refractory ascites in cirrhosis-a study protocol for a randomised trial ', Danish Medical Journal, vol. 68, no. 11 .
Gantzel, R H, Meyer, M, Mazgareanu, S, Aagaard, N K, Jepsen, P, Holzmeister, J, Watson, H & Grønbæk, H 2021, ' Ularitide as treatment of refractory ascites in cirrhosis – a study protocol for a randomised trial ', Danish Medical Journal, vol. 68, no. 12, A07210610 .
Aarhus University
Gantzel, R H, Meyer, M, Mazgareanu, S, Aagaard, N K, Jepsen, P, Holzmeister, J, Watson, H & Grønbæk, H 2021, ' Ularitide as treatment of refractory ascites in cirrhosis-a study protocol for a randomised trial ', Danish Medical Journal, vol. 68, no. 11 .
INTRODUCTION Ascites is a frequent complication to cirrhosis. When ascites becomes refractory to standard diuretic pharmacotherapy, patients are facing a median survival of less than one year and most likely a need for frequent hospitalisations due t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::1e5bbc4a9be0ae91b48b9eccb032ad63
https://pure.au.dk/portal/da/publications/ularitide-as-treatment-of-refractory-ascites-in-cirrhosis-a-study-protocol-for-a-randomised-trial(400aeb1f-2cd0-4322-a481-987507a125eb).html
https://pure.au.dk/portal/da/publications/ularitide-as-treatment-of-refractory-ascites-in-cirrhosis-a-study-protocol-for-a-randomised-trial(400aeb1f-2cd0-4322-a481-987507a125eb).html
Publikováno v:
International Journal of Pharmaceutics. 360:18-28
We compared a new formulation of ketoprofen (Diractin) based on ultradeformable vesicle (Transfersome) carriers with conventional topical gels with the drug (Gabrilen; Togal Mobil Gel; Fastum). Depending on water concentration, between a few percent
Publikováno v:
International Journal of Pharmaceutics. 360:29-39
We compared in vivo transport and biodistribution of ketoprofen applied on the skin in ultradeformable carriers (Diractin) or a conventional topical gel (Gabrilen) with oral drug (Oruvail); for reference we used in vitro study data. The drug from Gab
Publikováno v:
International Journal of Pharmaceutics. 359:190-197
We studied skin occlusion effects in vitro and in vivo on local and systemic delivery of ketoprofen across the organ, using the drug in a conventional non-occlusive topical gel (Togal Mobil-Gel), an occlusive tape (Mohrus), and the new targeted analg
Autor:
Stefan Mazgareanu, Bernhard J Lavins, Werner Kneer, Matthias Rother, Klaus Lehnhardt, Egbert J Seidel
Publikováno v:
Annals of the Rheumatic Diseases. 66:1178-1183
Objective: To compare epicutaneous ketoprofen in Transfersome (ultra-deformable vesicles, IDEA-033) versus oral celecoxib and placebo for relief of signs and symptoms in knee osteoarthritis. Methods: This was a multicentre, randomised, double-blind,
Autor:
Hans R. Gelderblom, Simone Schimmer, Stefanie Czub, Georg Gosztonyi, Markus Czub, Stefan Mazgareanu, Regine Hansen, Volker ter Meulen, Evi Werder, Jens Herold
Publikováno v:
Journal of Virology. 74:1775-1780
A pathogenetic hallmark of retroviral neurodegeneration is the affinity of neurovirulent retroviruses for microglia cells, while degenerating neurons are excluded from retroviral infections. Microglia isolated ex vivo from rats peripherally infected
Autor:
S. Schwender, Stefan Mazgareanu, Andreas Hein, Monika Demuth, Stefanie Czub, Markus Czub, Rüdiger Dörries, Martina Rappold
Publikováno v:
Virology. 214(1):239-244
A highly neuropathogenic retrovirus, NT40, was generated by serially passaging an infectious molecular clone of Friend murine leukemia virus, FB29, through F344 Fisher rats. NT40 induced severe neurological signs such as reflex abnormalities and atax
Autor:
Ulrich Vierl, Ilka Rother, Egbert J Seidel, Stefan Mazgareanu, Priscilla M Clarkson, Matthias Rother
Publikováno v:
Drug design, development and therapy
Matthias Rother1,2, Egbert J Seidel3, Priscilla M Clarkson4, Stefan Mazgareanu1, Ulrich Vierl1, ilka Rother21IDEA AG, Muenchen, Germany; 2X-pert Med GmbH, Graefelfing, Germany; 3Department Physical and Rehabilitation Medicine, Sophien- and Hufeland-C